Dr Reddy's stock records its sharpest weekly decline in three years

Shares of Dr Reddy's Laboratories topped the list of market losers due to heavy selling pressure this week. The pharma giant plunged more than 9 percent across five trading days after corporate developments concerning disruptions in semaglutide supply. These unexpected operational challenges pulled down the generally upbeat momentum seen in large-cap healthcare stocks.